Canadian Oil Sands Coverage Initiated at Morgan Stanley (COS)

Share on StockTwits

Investment analysts at Morgan Stanley started coverage on shares of Canadian Oil Sands (TSE:COS) in a note issued to investors on Wednesday. The firm set an “overweight” rating and a C$26.00 price target on the stock. Morgan Stanley’s price objective indicates a potential upside of 9.20% from the company’s current price.

COS has been the subject of a number of other recent research reports. Analysts at Barclays raised their price target on shares of Canadian Oil Sands from C$23.00 to C$25.00 in a research note on Monday. Separately, analysts at CIBC raised their price target on shares of Canadian Oil Sands from C$22.50 to C$23.00 in a research note on Thursday, July 17th. They now have a “sector perform” rating on the stock. Finally, analysts at Raymond James raised their price target on shares of Canadian Oil Sands from C$20.50 to C$25.00 in a research note on Monday, July 7th. They now have a “market perform” rating on the stock. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of C$24.05.

Shares of Canadian Oil Sands (TSE:COS) traded up 0.84% during mid-day trading on Wednesday, hitting $24.01. 553,557 shares of the company’s stock traded hands. Canadian Oil Sands has a 1-year low of $19.40 and a 1-year high of $24.68. The stock has a 50-day moving average of $23.74 and a 200-day moving average of $22.35. The company has a market cap of $11.635 billion and a P/E ratio of 14.01.

Canadian Oil Sands Limited is a pure investment opportunity in light, sweet crude oil. Through its 36.

Stay on top of analysts' coverage of Canadian Oil Sands Ltd with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Microsoft Delays Xbox One Launch in China
Microsoft Delays Xbox One Launch in China
Eli Lilly Receives Approval from FDA for Type 2 Diabetes Treatment
Eli Lilly Receives Approval from FDA for Type 2 Diabetes Treatment
Telefonica to Acquire Brazil Unit of Vivendi
Telefonica to Acquire Brazil Unit of Vivendi
Kindle Lineup Expanded By Amazon
Kindle Lineup Expanded By Amazon
Law Enforcement: Man Ingested Girlfriend’s Organs
Law Enforcement: Man Ingested Girlfriend’s Organs
Apple Confirms iPhone 6 Record Pre-Orders
Apple Confirms iPhone 6 Record Pre-Orders


Leave a Reply

 
© 2006-2014 WKRB News.